{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:18:41Z","timestamp":1777292321495,"version":"3.51.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["YJSZHYX202120"],"award-info":[{"award-number":["YJSZHYX202120"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Globally, blood pressure management strategies were ineffective, and a low percentage of patients receiving hypertension treatment had their blood pressure controlled. In this study, we aimed to build a medication prediction model by correlating patient attributes with medications to help physicians quickly and rationally match appropriate medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected clinical data from elderly hypertensive patients during hospitalization and combined statistical methods and machine learning (ML) algorithms to filter out typical indicators. We constructed five ML models to evaluate all datasets using 5-fold cross-validation. Include random forest (RF), support vector machine (SVM), light gradient boosting machine (LightGBM), artificial neural network (ANN), and naive Bayes (NB) models. And the performance of the models was evaluated using the micro-F1 score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our experiments showed that by statistical methods and ML algorithms for feature selection, we finally selected Age, SBP, DBP, Lymph, RBC, HCT, MCHC, PLT, AST, TBIL, Cr, UA, Urea, K, Na, Ga, TP, GLU, TC, TG, \u03b3-GT, Gender, HTN CAD, and RI as feature metrics of the models. LightGBM had the best prediction performance with the micro-F1 of 78.45%, which was higher than the other four models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LightGBM model has good results in predicting antihypertensive medication regimens, and the model can be beneficial in improving the personalization of hypertension treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1056263","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:30:23Z","timestamp":1669923023000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A comparative study of antihypertensive drugs prediction models for the elderly based on machine learning algorithms"],"prefix":"10.3389","volume":"9","author":[{"given":"Tiantian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoushu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B2","first-page":"143","volume":"119","author":"B Banegas","year":"2002","journal-title":"Anales de la Real Academia Nacional de Medicina"},{"key":"B3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5830\/CVJA-2013-002","article-title":"Hypertension and associated factors in older adults in South Africa","volume":"24","author":"Peltzer","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.jhh.1001380","article-title":"A high level of awareness but a poor control of hypertension among elderly Greeks. The Nemea primary care study","volume":"16","author":"Skliros","year":"2002","journal-title":"J Hum Hypertens."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.22605\/RRH1225","article-title":"Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece","volume":"10","author":"Triantafyllou","year":"2010","journal-title":"Rural Remote Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1471-2458-8-275","article-title":"Factors associated with hypertension prevalence, unawareness and treatment among Costa Rican elderly","volume":"8","author":"M\u00e9ndez-Chac\u00f3n","year":"2008","journal-title":"BMC Public Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","article-title":"Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys","volume":"394","year":"2019","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0895-7061(00)00259-4","article-title":"Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines","volume":"13","author":"Weisser","year":"2000","journal-title":"Am J Hypertens."},{"key":"B12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/dme.13858","article-title":"Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015","volume":"36","author":"Tabesh","year":"2019","journal-title":"Diabet Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/cpt.320","article-title":"The FDA's sentinel initiative-A comprehensive approach to medical product surveillance","volume":"99","author":"Ball","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","article-title":"The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)","volume":"96","author":"Jernberg","year":"2010","journal-title":"Heart."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00392-016-1025-6","article-title":"Electronic health records to facilitate clinical research","volume":"106","author":"Cowie","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12539-017-0271-2","article-title":"Risk-predicting model for incident of essential hypertension based on environmental and genetic factors with support vector machine","volume":"10","author":"Pei","year":"2018","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"637635","DOI":"10.1155\/2014\/637635","article-title":"Predicting increased blood pressure using machine learning","volume":"2014","author":"Golino","year":"2014","journal-title":"J Obes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12020-021-02745-7","article-title":"Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension","volume":"73","author":"Wang","year":"2021","journal-title":"Endocrine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.11855\/j.issn.0577-7402.2020.07.10","article-title":"Researches on the illness risk of essential hypertension complicated with coronary heart disease based on machine learning algorithm","volume":"7","author":"Gong","year":"2020","journal-title":"Med J Chin Peoples Liberation Army."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00396","DOI":"10.1002\/prp2.396","article-title":"Machine learning of big data in gaining insight into successful treatment of hypertension","volume":"6","author":"Koren","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101841","DOI":"10.1016\/j.artmed.2020.101841","article-title":"Characterizing the critical features when personalizing antihypertensive drugs using spectrum analysis and machine learning methods","volume":"104","author":"Chunyu","year":"2020","journal-title":"Artif Intellig Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12911-021-01739-9","article-title":"Identifying drug-related attributes to personalise antihypertensive agents: the outcome report of patients receiving metoprolol therapy","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Inform Decis Mak."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1063\/1.106515","article-title":"An introduction to variable and feature selection","volume":"3","author":"Guyon","year":"2003","journal-title":"J Mach Learn Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.113.00863","article-title":"Recent clinical trials of hypertension management","volume":"62","author":"Jennings","year":"2013","journal-title":"Hypertension."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Pra","volume":"19","author":"Whelton","year":"2017","journal-title":"Hypertension."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0895-7061(02)03260-0","article-title":"Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling","volume":"16","author":"Vlase","year":"2003","journal-title":"Am J Hypertens."},{"key":"B32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.6121\/j.cnki.cn45-1347\/r.2015.05.01","article-title":"Protective effect of perindopril on target organ in elderly patients with mild-to-moderate hypertension","volume":"10","author":"Wu","year":"2015","journal-title":"Intern Med China."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.2011.574","article-title":"Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion","volume":"305","author":"Stolarz-Skrzypek","year":"2011","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3969\/j.issn.1673-4130.2016.21.054","article-title":"Analysis of blood routine and some biochemical indexes in elderly hypertensive patients","volume":"37","author":"Yang","year":"2016","journal-title":"Int J Lab Med."},{"key":"B35","first-page":"109","article-title":"Influence of white blood cell count on disease control in elderly patients with essential hypertension","volume":"36","author":"Wang","year":"2015","journal-title":"J Med Forum"},{"key":"B36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/0002-8703(94)90679-3","article-title":"Hematocrit and the risk of cardiovascular disease\u2014the Framingham Study: a 34-year follow-up","volume":"127","author":"Gagnon","year":"1994","journal-title":"Am Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3969\/j.issn.16721349.2014.09.007","article-title":"Serum total protein and its related factorin very elderly hypertensive patients","volume":"12","author":"Wei","year":"2014","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.15887\/j.cnki.13-1389\/r.2012.09.059","article-title":"The relationship between level of serum uric acid,total bilirubin and hypertension","volume":"5","author":"Wang","year":"2012","journal-title":"Clin Ration Drug Use"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e006503","DOI":"10.1161\/JAHA.117.006503","article-title":"Circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end-stage disease (PREVEND) prospective study and a Mendelian randomization approach","volume":"6","author":"Kunutsor","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","article-title":"Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group","volume":"297","year":"1988","journal-title":"BMJ."},{"key":"B41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.280.10.885","article-title":"Sodium reduction and weight loss for elderly patients with hypertension","volume":"280","author":"Alderman","year":"1998","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"m315","DOI":"10.1136\/bmj.m315","article-title":"Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials","volume":"368","author":"Huang","year":"2020","journal-title":"BMJ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.117.09928","article-title":"Relation of dietary sodium (salt) to blood pressure and its possible modulation by other dietary factors: the INTERMAP study","volume":"71","author":"Stamler","year":"2018","journal-title":"Hypertension."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II\u2013induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3969\/j.issn.1003-6350.2018.19.037","article-title":"Research progress in the relationship between neutrophil\/lymphocyte and essential hypertension","volume":"29","author":"Gao","year":"2018","journal-title":"Hainan Med J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/diagnostics11091714","article-title":"Diagnosis of diabetes mellitus using gradient boosting machine (LightGBM)","volume":"11","author":"Rufo","year":"2021","journal-title":"Diagnostics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-981-13-2826-8_27","article-title":"A Weighted Bagging LightGBM Model for Potential lncRNA-Disease Association Identification","author":"Chen","year":"2018","journal-title":"Bio-inspired Computing: Theories and Applications. Communications in Computer and Information Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1109\/TNNLS.2017.2729778","article-title":"A novel consistent random forest framework: Bernoulli random forests","volume":"29","author":"Wang","year":"2018","journal-title":"IEEE Trans Neural Netw Learn Syst."},{"key":"B49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/978-3-642-34062-8_32","article-title":"New machine learning algorithm: random forest","author":"Liu","year":"2012","journal-title":"Information Computing and Applications. Lecture Notes in Computer Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/978-981-10-4166-2_89","article-title":"Diagnosis of chronic kidney disease by using random forest","author":"Subasi","year":"2017","journal-title":"CMBEBIH 2017. IFMBE Proceedings"},{"key":"B51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/978-981-10-5427-3_63","article-title":"Heart disease prediction system using random forest","author":"Singh","year":"2017","journal-title":"Advances in Computing and Data Sciences. Communications in Computer and Information Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s11227-018-2469-4","article-title":"Optimal feature-based multi-kernel SVM approach for thyroid disease classification","volume":"76","author":"Shankar","year":"2020","journal-title":"J Supercomput."},{"key":"B53","first-page":"3107","article-title":"Classification and prediction of heart disease risk using data mining techniques of support vector machine and artificial neural network","author":"Radhimeenakshi","year":"2016","journal-title":"2016 3rd International Conference on Computing for Sustainable Global Development (INDIACom)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s41256-020-00175-y","article-title":"Application of artificial neural networks to predict the COVID-19 outbreak","volume":"5","author":"Niazkar","year":"2020","journal-title":"Glob Health Res Policy."},{"key":"B55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/THC-151071","article-title":"Machine learning models in breast cancer survival prediction","volume":"24","author":"Montazeri","year":"2016","journal-title":"Technol Health Care."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1056263\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:47:25Z","timestamp":1669924045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1056263\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":55,"alternative-id":["10.3389\/fcvm.2022.1056263"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1056263","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"1056263"}}